Literature DB >> 8689917

Changes in parietal cell structure and function in HIV disease.

G Lake-Bakaar1, M Elsakr, N Hagag, S Lyubsky, J Ahuja, B Craddock, R T Steigbigel.   

Abstract

The mechanisms underlying acid secretory failure in patients with HIV disease are unknown. We evaluated, in a series of preliminary studies, changes associated with parietal cell structure and function in early and late HIV disease, in an attempt to elucidate possible underlying mechanisms. Gastric acid and intrinsic factor secretion, vitamin B12 absorption, and light and electron microscopic evaluation of gastric mucosa were evaluated in patients with early and late HIV infection (AIDS) and compared to non-HIV-infected controls. Immunolocalization of HIV-related antigens in gastric mucosa was also examined. Fasting gastric juice pH and intrinsic factor (IF) concentration in AIDS and HIV infected subjects were significantly different from controls (P = 0.012 and P = 0.025, respectively for pH, and 0.029 and 0.035 for IF; ANOVA LSD test). By contrast, maximal acid output (MAO) was significantly lower in AIDS, but not HIV-infected subjects (P = 0.043 and P = 0.322, respectively). Similarly, Schilling test phases 1 and 2 results were significantly lower in AIDS, but not HIV-infected subjects. Varying degrees of vacuolar degeneration of parietal cells were seen on light microscopy. On electron microscopy (EM), tubulovesicles were reduced and intracellular canaliculi dilated with striking loss of microvilli. Immunofluorescent staining with antibodies to gp120, gp41, p24, and p17 demonstrated positive punctate signals in the cytoplasm of gastric glands, which includes parietal cells. Immunogold EM with anti-gp120, localized predominantly to the microvilli of intracellular canaliculi in parietal cells. Abnormal secretory function of parietal cells occurs early in HIV disease, affects acid as well as intrinsic factor secretion, and is associated with morphological changes in the acid secretory apparatus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689917     DOI: 10.1007/bf02088565

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Ultrastructural markers in circulating lymphocytes of subjects at risk for AIDS.

Authors:  J M Orenstein; G L Simon; C M Kessler; R S Schulof
Journal:  Am J Clin Pathol       Date:  1985-11       Impact factor: 2.493

3.  Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS.

Authors:  P C Belitsos; J K Greenson; J H Yardley; J R Sisler; J G Bartlett
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

Review 4.  Tubuloreticular structures and cylindrical confronting cisternae: a review.

Authors:  J Y Luu; D Bockus; F Remington; M A Bean; S P Hammar
Journal:  Hum Pathol       Date:  1989-07       Impact factor: 3.466

5.  Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

Authors:  G Lake-Bakaar; W Tom; D Lake-Bakaar; N Gupta; S Beidas; M Elsakr; E Straus
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

6.  An assay for intrinsic factor based on blocking of the R binder of gastric juice by cobinamide.

Authors:  J A Begley; A Trachtenberg
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

7.  Vitamin B-12 abnormalities in HIV-infected patients.

Authors:  A F Remacha; A Riera; J Cadafalch; E Gimferrer
Journal:  Eur J Haematol       Date:  1991-07       Impact factor: 2.997

8.  Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome.

Authors:  G R Harriman; P D Smith; M K Horne; C H Fox; S Koenig; E E Lack; H C Lane; A S Fauci
Journal:  Arch Intern Med       Date:  1989-09

9.  Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders.

Authors:  R L Burkes; H Cohen; M Krailo; R M Sinow; R Carmel
Journal:  Eur J Haematol       Date:  1987-02       Impact factor: 2.997

10.  Gastric acid secretion in HIV-1 infection.

Authors:  R T Shaffer; L J LaHatte; J W Kelly; S Kadakia; J G Carrougher; R F Keate; E C Starnes
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

View more
  8 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report.

Authors:  Brandi Giovanni; Carlo Calabrese; Roberto Manfredi; Anna Maria Pisi; Giulio Di Febo; Rossella Hakim; Giovanna Cenacchi; Guido Biasco
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 3.  Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.

Authors:  Paul Kelly; Haroon Saloojee; Jennifer Y Chen; Raymond T Chung
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 4.  A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.

Authors:  Ahmad Y Abuhelwa; David J R Foster; Richard N Upton
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

5.  HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects.

Authors:  Jackson K Mukonzo; Sarah Nanzigu; Dinko Rekić; Paul Waako; Daniel Röshammar; Michael Ashton; Jasper Ogwal-Okeng; Lars L Gustafsson; Eleni Aklillu
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

6.  Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus.

Authors:  Parya Saberi; Dilrini K Ranatunga; Charles P Quesenberry; Michael J Silverberg
Journal:  Pharmacotherapy       Date:  2011-03       Impact factor: 4.705

7.  Vitamin C Improves Dasatinib Concentrations Under Hypochlorhydric Conditions of the Simulated Stomach Duodenum Model.

Authors:  Fouad S Moghrabi; Aktham Aburub; Hala M Fadda
Journal:  Pharm Res       Date:  2022-07-01       Impact factor: 4.580

8.  Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial.

Authors:  Paul Kelly; Tamara Shawa; Stayner Mwanamakondo; Rose Soko; Geoff Smith; G Robin Barclay; Ian R Sanderson
Journal:  BMC Gastroenterol       Date:  2010-07-06       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.